新闻资讯

新闻资讯
PEG衍生物 首页>新闻资讯

2025-11-13 10:02:36

Sorafenib (BAY 43-9006) tosylate | 475207-59-1

Name:Sorafenib (BAY 43-9006) tosylate
Synonyms:BAY 43-9006 tosylate,NSC-724772 tosylate
CAS Number:475207-59-1
Formula:C21H16ClF3N4O3.C7H8O3S
M.w.:637.03
DMSO (mg/mL)Max Solubility:127
DMSO (mM)Max Solubility:199.36
Form:Tosylate
SMILES:CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2.CC4=CC=C(C=C4)[S](O)(=O)=O
ALogP:5.824
Target:Apoptosis related,Autophagy,c-Kit,Ferroptosis,FGFR,FLT3,PDGFR,Raf,VEGFR
Pathway:MAPK
Information:Sorafenib tosylate (BAY 43-9006 tosylate,NSC-724772 tosylate) is a multikinase inhibitor of Raf-1 and B-Raf with IC50 of 6 nM and 22 nM in cell-free assays, respectively. Sorafenib Tosylate inhibits VEGFR-2, VEGFR-3, PDGFR-β, Flt-3 and c-KIT with IC50 of 90 nM, 20 nM, 57 nM, 59 nM and 68 nM, respectively. Sorafenib Tosylate induces autophagy and apoptosis and activates ferroptosis with anti-tumor activity.
德尔塔生物是您专业的小分子合成定制合作伙伴。我们专注于为医药研发、材料科学及学术研究提供从毫克到公斤级的一站式合成解决方案。无论是常规分子、复杂手性化合物、同位素标记物还是特定杂质,我们的资深团队都能凭借先进技术平台高效完成。我们始终坚持严格的质量控制,确保产品纯度与结构准确,并恪守保密承诺。选择德尔塔生物,就是选择可靠与精准,让我们以卓越的合成能力,加速您的创新突破。欢迎垂询,定制您的专属分子。